The second phase of the Merck China Biosafety Testing and Experimental Center project has been completed and officially put into use
lee382
发表于 2023-11-21 18:48:50
1287
0
0
On November 21st, Merck announced that the second phase of its China Biosafety Testing and Experimental Center project was completed and officially opened in Shanghai, adding an additional 1500 square meters to the first phase. The project started construction in 2022 with a total investment of 29 million euros, strengthening Merck's BioReliance& Reg; The biosafety testing service capability has further met the needs of local biosafety testing.
The reporter noticed that the testing and experimental center is Merck's first biosafety testing and experimental facility in the Chinese market, which can help customers obtain diversified biosafety testing services locally, from preclinical development to commercial launch, including cell bank testing and batch release testing.
The opening of the second phase of the laboratory further deepens the partnership between the company and Chinese customers. The company's biosafety testing and experimental center located in Shanghai can now provide localized testing services with over 75 years of international experience to the Chinese market, "said Dirk Lange, global head of life sciences services for Merck's life sciences business
It is understood that the first phase of the Merck China Biosafety Testing and Experimental Center's project is to provide virus clearance verification services, which is one of the most critical steps in drug development. The second phase of the project has added cell bank testing and batch release testing services to help biopharmaceutical customers ensure the safety, purity, and identification of their cell banks. The testing and experimental center also provides batch release testing services that meet GMP requirements for harvested and raw fluids, in order to meet the requirements for pre clinical and clinical research biological products as well as approved biological products.
Caine Leong, Asia Pacific Business Director of Merck Life Sciences Biomedical Testing Services, stated that since the official opening of the virus clearance laboratory last year, the company has provided high-level testing services and a global regulatory network for Chinese customers. The virus clearance laboratory enables local customers to meet specific national and even global regulatory standards and ensure the virus safety of their products. With the launch of the second phase project, the Merck team will continue to deepen cooperation with customers.
It is worth mentioning that with the completion of the second phase of the center construction, Merck can provide extensive biosafety testing services for monoclonal antibodies, other recombinant proteins, and cell and gene therapies in China. The Shanghai Testing and Experimental Center will become an important member of Merck's global biosafety testing and experimental service network. Other experimental centers providing this service are located in Singapore, Sterling and Glasgow in the UK, and Rockville, Maryland in the United States, each sharing the same global expertise, standards, and operational systems.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- The spillover effect of the CIIE drives Sanofi's China business to accelerate and deepen its localization layout
- The Nasdaq China Golden Dragon Index rose by over 3%, while Xiaopeng Motors rose by over 15%
- Chinese assets have exploded! Is Trump planning to fire Powell? Latest News
- Last night, oil prices fell across the board! Most popular Chinese concept stocks experience a pullback, with the Nasdaq China Golden Dragon Index falling 4.74%
- Nike: Help China become a major running country and expand its local running layout
- Directly hitting the CIIE | Sony China: Technology continues to create emotions
- Xie Lijuan, General Manager of Sanofi Pharmaceuticals China: "Jinbo Baby" creates a "miracle" and continues to build immune leadership
- Industrial Securities: Yum! China's performance is impressive, increasing dividend payout and repurchase limit
- Republicans in the US House of Representatives push to cancel China's permanent normal trade relations status. Ministry of Foreign Affairs: Attempting to reverse history
- The Nasdaq China Golden Dragon Index closed up 0.59%, with most popular Chinese concept stocks rising
-
自美国大选结果出炉、美国前总统特朗普宣布胜选以来,作为其本次竞选的“大金主”、特斯拉首席执行官埃隆·马斯克也赢麻了。 截至上周五美股收盘,特斯拉股价单日暴涨8.19%,总市值也重新站稳1万亿美元关口 ...
- chpuu
- 前天 10:56
- 支持
- 反对
- 回复
- 收藏
-
本报讯 (记者李豪悦)11月12日,腾讯音乐娱乐集团(以下简称“腾讯音乐”)宣布其截至2024年9月30日止第三季度的未经审计财务业绩。 2024年第三季度,腾讯音乐娱乐集团业绩表现稳健,总收入为70.2亿元,同 ...
- 覃志辉
- 昨天 20:07
- 支持
- 反对
- 回复
- 收藏
-
波音公司当地时间11月11日表示,该公司负责商用飞机品质的高级副总裁伊丽莎白·伦德(Elizabeth Lund)将于12月退休。伦德在波音公司工作了33年,在1月5日阿拉斯加航空公司一架新的737 MAX 9飞机在空中舱门脱落 ...
- charles1121
- 昨天 13:15
- 支持
- 反对
- 回复
- 收藏
-
近日,福特纵横户外主题乐园于“孔孟之乡、运河之都”——中国济宁正式揭牌。该公园是继福特在北美成功打造了六座“Bronco Nation”福特烈马公园后,全球第七座、北美以外唯一、也是中国首座户外主题乐园。 ...
- fly520
- 前天 13:27
- 支持
- 反对
- 回复
- 收藏